BeOne Medicines Ltd. ONC
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2016-03-02
Chart by TradingView
7/9
Piotroski F — financial health
1.78
Altman Z″ — distress risk · grey
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $5.3B | $3.8B | $2.5B | $1.4B | $1.2B |
| Gross profit | $4.7B | $3.2B | $2.1B | $1.1B | $1.0B |
| Operating income | $447.1M | -$568.2M | -$1.2B | -$1.8B | -$1.4B |
| Net income | $286.9M | -$644.8M | -$881.7M | -$2.0B | -$1.5B |
| Operating cash flow | $1.1B | -$140.6M | -$1.2B | -$1.5B | -$1.3B |
| Free cash flow | $941.7M | -$633.3M | -$1.7B | -$1.8B | -$1.6B |
| Total assets | $8.2B | $5.9B | $5.8B | $6.4B | $8.5B |
| Total liabilities | $3.8B | $2.6B | $2.3B | $2.0B | $2.4B |
| Shareholders' equity | $4.4B | $3.3B | $3.5B | $4.4B | $6.1B |
| Ratios | |||||
| Gross margin | 87.5% | 84.4% | 84.5% | 79.8% | 86.0% |
| Operating margin | 8.4% | -14.9% | -49.1% | -126.4% | -122.3% |
| Net margin | 5.4% | -16.9% | -35.9% | -141.5% | -123.9% |
| FCF margin | 17.6% | -16.6% | -69.9% | -128.7% | -132.8% |
| Return on assets | 3.5% | -10.9% | -15.2% | -31.4% | -17.1% |
| Return on equity | 6.6% | -19.4% | -24.9% | -45.7% | -23.8% |
| Debt / equity | 0.19× | 0.05× | 0.06× | 0.05× | 0.03× |
| Current ratio | 3.41 | 1.80 | 2.32 | 3.55 | 4.76 |
| Revenue growth | 40.2% | 55.0% | 73.7% | 20.4% | 280.8% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 65,456 | $19.4M |
Why these scores methodology →
Piotroski F-score: 7/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 1.78 (grey)
- Working capital / assets 0.538
- Retained earnings / assets -1.016
- EBIT / assets 0.055
- Equity / liabilities 1.139
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001651308 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.